Maryanne Reilly-Spong1, Diane Reibel2, Terry Pearson3, Pat Koppa4, Cynthia R Gross5. 1. University of Minnesota College of Pharmacy, United States. 2. Jefferson-Myrna Brind Center of Integrative Medicine Mindfulness Institute, United States. 3. University of Minnesota Center for Spirituality & Healing, United States. 4. Public Health Consultants, LLC, United States. 5. University of Minnesota College of Pharmacy, United States; University of Minnesota School of Nursing, United States. Electronic address: gross002@umn.edu.
Abstract
BACKGROUND:Mindfulness-based stress reduction (MBSR) has demonstrated benefits for stress-related symptoms; however, for patients with burdensome treatment regimens, multiple co-morbidities and mobility impairment, time and travel requirements pose barriers to MBSR training. PURPOSE: To describe the design, rationale and feasibility results of Journeys to Wellness, a clinical trial of mindfulness training delivered in a novel workshop and teleconference format. The trial aim is to reduce symptoms and improve quality of life in people waiting for a kidney transplant. METHODS: The standard 8-week MBSR program was reconfigured for delivery as two in-person workshops separated in time by six weekly teleconferences (tMBSR). A time and attention comparison condition (tSupport) was created using the workshop-telephone format. FEASIBILITY RESULTS:Kidney transplant candidates (N = 63) were randomly assigned to tMBSR or tSupport: 87% (n = 55) attended ≥ 1 class, and for these, attendance was high (6.6 ± 1.8 tMBSR and 7.0 ± 1.4 tSupport sessions). Fidelity monitoring found that all treatment elements were delivered as planned and few technical problems occurred. Patients in both groups reported high treatment satisfaction, but more tMBSR (83%) than tSupport (43%) participants expected their intervention to be quite a bit or extremely useful for managing their health. Symptoms and quality of life outcomes collected before (baseline, 8 weeks and 6 months) and after kidney transplantation (2, 6 and 12 months) will be analyzed for efficacy. CONCLUSIONS:tMBSR is an accessible intervention that may be useful to people with a wide spectrum of health conditions. Clinicaltrials.gov: NCT01254214.
RCT Entities:
BACKGROUND: Mindfulness-based stress reduction (MBSR) has demonstrated benefits for stress-related symptoms; however, for patients with burdensome treatment regimens, multiple co-morbidities and mobility impairment, time and travel requirements pose barriers to MBSR training. PURPOSE: To describe the design, rationale and feasibility results of Journeys to Wellness, a clinical trial of mindfulness training delivered in a novel workshop and teleconference format. The trial aim is to reduce symptoms and improve quality of life in people waiting for a kidney transplant. METHODS: The standard 8-week MBSR program was reconfigured for delivery as two in-person workshops separated in time by six weekly teleconferences (tMBSR). A time and attention comparison condition (tSupport) was created using the workshop-telephone format. FEASIBILITY RESULTS: Kidney transplant candidates (N = 63) were randomly assigned to tMBSR or tSupport: 87% (n = 55) attended ≥ 1 class, and for these, attendance was high (6.6 ± 1.8 tMBSR and 7.0 ± 1.4 tSupport sessions). Fidelity monitoring found that all treatment elements were delivered as planned and few technical problems occurred. Patients in both groups reported high treatment satisfaction, but more tMBSR (83%) than tSupport (43%) participants expected their intervention to be quite a bit or extremely useful for managing their health. Symptoms and quality of life outcomes collected before (baseline, 8 weeks and 6 months) and after kidney transplantation (2, 6 and 12 months) will be analyzed for efficacy. CONCLUSIONS:tMBSR is an accessible intervention that may be useful to people with a wide spectrum of health conditions. Clinicaltrials.gov: NCT01254214.
Authors: Rachel L Perlman; Fredric O Finkelstein; Lei Liu; Erik Roys; Margaret Kiser; George Eisele; Sally Burrows-Hudson; Joseph M Messana; Nathan Levin; Sanjay Rajagopalan; Friedrich K Port; Robert A Wolfe; Rajiv Saran Journal: Am J Kidney Dis Date: 2005-04 Impact factor: 8.860
Authors: Cynthia R Gross; Mary Jo Kreitzer; William Thomas; Maryanne Reilly-Spong; Michel Cramer-Bornemann; John A Nyman; Patricia Frazier; Hassan N Ibrahim Journal: Altern Ther Health Med Date: 2010 Sep-Oct Impact factor: 1.305
Authors: Amy D Waterman; John Devin Peipert; Anna-Michelle McSorley; Christina J Goalby; Jennifer L Beaumont; Leanne Peace Journal: Am J Kidney Dis Date: 2019-06-19 Impact factor: 8.860
Authors: Jessica K Stevenson; Zoe C Campbell; Angela C Webster; Clara K Chow; Allison Tong; Jonathan C Craig; Katrina L Campbell; Vincent Ws Lee Journal: Cochrane Database Syst Rev Date: 2019-08-06
Authors: Cynthia R Gross; Maryanne Reilly-Spong; Taehwan Park; Ruizhi Zhao; Olga V Gurvich; Hassan N Ibrahim Journal: Contemp Clin Trials Date: 2017-03-22 Impact factor: 2.226
Authors: R M R Tulloh; V Garratt; J Tagney; J Turner-Cobb; E Marques; R Greenwood; L Howard; W Gin-Sing; A Barton; P Ewings; P Craggs; W Hollingworth Journal: Pilot Feasibility Stud Date: 2018-05-21
Authors: Bruno Nunes Razzera; Angélica Nickel Adamoli; Maitê Freitas Ranheiri; Margareth da Silva Oliveira; Ana Maria Pandolfo Feoli Journal: J Bras Nefrol Date: 2022 Jan-Mar